Reprocessing service designed to help hospitals and vein clinics
reduce costs and cut down on medical waste
WAYNE, Pa.--(BUSINESS WIRE)--Jan. 9, 2018--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care and surgery, today announced that more
than 200,000 ClosureFast® Catheters have been
successfully reprocessed by the company’s partner, Northeast Scientific,
Inc. (NES), since NES received FDA clearance for reprocessing the
popular vein ablation catheter in 2011.
The ClosureFast® Catheter is one of the most widely
used devices in the United States for performing endovenous treatment of
venous reflux disease, a serious medical condition affecting blood
circulation in the lower legs that causes varicose veins.
“As we approach the sixth anniversary of the launch of our reprocessing
service and mark the attainment of another significant milestone in the
number of ClosureFast® Catheters that have been
successfully reprocessed, we are proud of the exceptional value this
service continues to deliver to our customers,” said Stewart Strong,
President and General Manager of the Interventional business unit of
Teleflex. “The reprocessing service is designed to help hospitals and
vein clinics reduce costs and cut down on medical waste, objectives that
are at the very core of Teleflex’s commitment to cost-effective
healthcare.”
Teleflex is offering the ClosureFast® Catheter
reprocessing service under contract with NES, an established third-party
reprocessor of medical devices. NES received 510(k) clearance from the
U.S. Food and Drug Administration on November 30, 2011 for reprocessing
the ClosureFast® Catheter. Since the reprocessing
service was introduced jointly by NES and Vascular Solutions, Inc. in
January 2012, several hundred U.S. hospitals and vein clinics have
enrolled in the program.
“Since Teleflex’s acquisition of Vascular Solutions in February 2017, we
have been very pleased to be working in collaboration with NES. We share
the commitment to helping hospitals and vein clinics reduce costs and
cut down on medical waste,” said Strong. “We have recently augmented the
level of customer service for the ClosureFast®
Catheter reprocessing program by introducing an in-house sales team to
support the ongoing efforts of our direct sales force.”
Craig Allmendinger, Chief Executive Officer of NES, commented, “We are
gratified by the achievements of the ClosureFast®
Catheter reprocessing service. The reprocessed vein ablation catheters
have demonstrated an excellent record for a sustained period of time and
the program has earned the respect of a growing number of vein clinic
practitioners. With Teleflex’s vast experience in the vein clinic market
and its focus on the needs of its physician customers and patient
outcomes, we look forward to the continued success of the program.”
In addition to offering the reprocessing service for ClosureFast®
Catheters, Teleflex markets a full range of accessory products that are
needed to perform both RF- and laser-based vein ablation procedures. The
company offers procedure packs designed for either RF or laser
procedures, micro-introducers and 7F micro-HV kits, 0.018” and 0.025”
guidewires, 18G echogenic needles for percutaneous entry, products for
administering tumescent anesthesia, and disposable vein hooks for use in
phlebectomy procedures.
About Northeast Scientific
Northeast Scientific, Inc. (NES), a privately-held company headquartered
in Waterbury, Connecticut, is registered with the U.S. Food and Drug
Administration as both a reprocessor of single-use medical devices and
as a manufacturer. NES recently relocated to a new 20,000 square-foot
facility specifically designed for its operations. Founded in 2005, NES
received its first 510(k) clearance in 2007 and is developing multiple
510(k)s for the interventional markets. NES performs all reprocessing
and manufacturing on site and is ISO 13485 registered. NES is not
affiliated with the original equipment manufacturers of the devices it
reprocesses. For more information about NES, visit the company’s website
at www.smarthealth-care.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
ClosureFast is a registered trademark of Covidien LP (a subsidiary of
Medtronic plc). Reprocessing of ClosureFast®
Catheters is performed by Northeast Scientific, Inc. and is not licensed
by or affiliated in any way with Covidien, Covidien LP, VNUS Medical
Technologies, Inc., Tyco Healthcare Group, LP, or Medtronic plc.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rüsch, and Weck are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates, in the U.S. and/or other
countries.
© 2018 Teleflex Incorporated. All rights reserved. MC-003836
View source version on businesswire.com: http://www.businesswire.com/news/home/20180109005353/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836